Literature DB >> 10508011

Beta-lactamase production in Prevotella intermedia, Prevotella nigrescens, and Prevotella pallens genotypes and in vitro susceptibilities to selected antimicrobial agents.

J Mättö1, S Asikainen, M L Väisänen, B Von Troil-Lindén, E Könönen, M Saarela, K Salminen, S M Finegold, H Jousimies-Somer.   

Abstract

The present study investigated the beta-lactamase production of 73 Prevotella intermedia, 84 Prevotella nigrescens, and 14 Prevotella pallens isolates and their in vitro susceptibilities to six antimicrobial agents. The P. intermedia and P. nigrescens isolates were recovered from oral and extraoral samples obtained from subjects in two geographic locations from 1985 to 1995. The clonality of the beta-lactamase-positive and beta-lactamase-negative isolates and the clustering of the genotypes were studied by arbitrarily primed-PCR fingerprinting. beta-Lactamase production was detected in 29% of P. intermedia isolates, 29% of P. nigrescens isolates, and 57% of P. pallens isolates. No difference in the frequencies of beta-lactamase production by P. intermedia and P. nigrescens between isolates from oral and extraoral sites, between isolates obtained at different time periods, or between P. intermedia isolates from different geographic locations was observed. However, the P. nigrescens isolates from the United States were significantly more frequently (P = 0.015) beta-lactamase positive than those from Finland. No association between the genotypes and beta-lactamase production or between the genotypes and the sources of the isolates was found. The penicillin G MICs at which 90% of the isolates were inhibited were 8 microg/ml for P. intermedia, 8 microg/ml for P. nigrescens, and 16 microg/ml for P. pallens. For the beta-lactamase-negative isolates, the corresponding values were 0.031, 0.031, and 0.125 microg/ml, and for the beta-lactamase-positive isolates, the corresponding values were 16, 8, and 32 microg/ml. All isolates were susceptible to amoxicillin-clavulanate, cefoxitin, metronidazole, azithromycin, and trovafloxacin. The MICs of amoxicillin-clavulanate and cefoxitin were relatively higher for the beta-lactamase-positive population than for the beta-lactamase-negative population.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10508011      PMCID: PMC89487          DOI: 10.1128/AAC.43.10.2383

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

1.  beta-lactamase production by oral pigmented Prevotella species isolated from young children.

Authors:  E Könönen; S Nyfors; J Mättö; S Asikainen; H Jousimies-Somer
Journal:  Clin Infect Dis       Date:  1997-09       Impact factor: 9.079

2.  Antibiotic resistance in an oral isolate of Prevotella intermedia.

Authors:  C B Walker; L C Bueno
Journal:  Clin Infect Dis       Date:  1997-09       Impact factor: 9.079

3.  Susceptibility testing of anaerobes: old problems, new options?

Authors:  H M Wexler; E Molitoris; D Molitoris
Journal:  Clin Infect Dis       Date:  1997-09       Impact factor: 9.079

4.  In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.

Authors:  H M Wexler; E Molitoris; D Molitoris; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

5.  Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.

Authors:  P C Appelbaum; S K Spangler; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

6.  Comparative in vitro activities of trovafloxacin (CP 99,219) and other antimicrobials against clinically significant anaerobes.

Authors:  K E Aldridge; D Ashcraft; K A Bowman
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

7.  Distribution and genetic analysis of oral Prevotella intermedia and Prevotella nigrescens.

Authors:  J Mättö; M Saarela; B von Troil-Lindén; E Könönen; H Jousimies-Somer; H Torkko; S Alaluusua; S Asikainen
Journal:  Oral Microbiol Immunol       Date:  1996-04

8.  Comparison of activities of trovafloxacin (CP-99,219) and five other agents against 585 anaerobes with use of three media.

Authors:  D W Hecht; J R Osmolski
Journal:  Clin Infect Dis       Date:  1996-12       Impact factor: 9.079

9.  A retrospective review of cases of anaerobic empyema and update of bacteriology.

Authors:  R Civen; H Jousimies-Somer; M Marina; L Borenstein; H Shah; S M Finegold
Journal:  Clin Infect Dis       Date:  1995-06       Impact factor: 9.079

10.  Penicillin resistance in the subgingival microbiota associated with adult periodontitis.

Authors:  S A Kinder; S C Holt; K S Korman
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

View more
  8 in total

1.  Antibiotic resistance in bacteria isolated from subgingival plaque in a norwegian population with refractory marginal periodontitis.

Authors:  Trude Handal; Dominique A Caugant; Ingar Olsen
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

Review 2.  Potential Contributions of Anaerobes in Cystic Fibrosis Airways.

Authors:  Christina S Thornton; Michael G Surette
Journal:  J Clin Microbiol       Date:  2021-02-18       Impact factor: 5.948

3.  Removable denture is a risk indicator for peri-implantitis and facilitates expansion of specific periodontopathogens: a cross-sectional study.

Authors:  Jasmin Grischke; Szymon P Szafrański; Uthayakumar Muthukumarasamy; Susanne Haeussler; Meike Stiesch
Journal:  BMC Oral Health       Date:  2021-04-01       Impact factor: 2.757

4.  Pharmacokinetic/pharmacodynamic evaluation of antimicrobial treatments of orofacial odontogenic infections.

Authors:  Arantxa Isla; Andrés Canut; Alicia R Gascón; Alicia Labora; Bruno Ardanza-Trevijano; Maria Angelés Solinís; Jose Luis Pedraz
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 5.577

5.  Prevotella melaninogenica, a Sentinel Species of Antibiotic Resistance in Cystic Fibrosis Respiratory Niche?

Authors:  Claudie Lamoureux; Charles-Antoine Guilloux; Elise Courteboeuf; Stéphanie Gouriou; Clémence Beauruelle; Geneviève Héry-Arnaud
Journal:  Microorganisms       Date:  2021-06-11

6.  Susceptibility of strict and facultative anaerobes Isolated from endodontic infections to metronidazole and beta-lactams.

Authors:  Elerson Gaetti-Jardim Júnior; Luís Fernando Landucci; Samira Ambar Lins; Evanice Menezes Marçal Vieira; Sérgio Ricardo de Oliveira
Journal:  J Appl Oral Sci       Date:  2007-12       Impact factor: 2.698

Review 7.  Azithromycin: The First Broad-spectrum Therapeutic.

Authors:  Anton Firth; Praveen Prathapan
Journal:  Eur J Med Chem       Date:  2020-08-19       Impact factor: 6.514

8.  Azithromycin for COVID-19: More Than Just an Antimicrobial?

Authors:  Nathalie Bleyzac; Sylvain Goutelle; Laurent Bourguignon; Michel Tod
Journal:  Clin Drug Investig       Date:  2020-08       Impact factor: 2.859

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.